Cellromax Science Co., Ltd.

471820· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩4,015-0.37%

2026-09-18

Financials

Valuation Metrics

Cellromax Science Co., Ltd.'s Market Cap is ₩454B. At end of 2025 it was ₩735B. Ranked #1828 of 2,421 in KR market (top 76%), #1122 of 1,640 on KOSDAQ (top 68%), #192 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 83%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	45.38B KRW	KR#1,828/2,421 Sec#192/231
Revenue	19.60B KRW	KR#2,139/2,421 Sec#156/231
Net Income	2.97B KRW	KR#1,347/2,421 Sec#94/231
Total Assets	50.54B KRW	KR#2,203/2,421 Sec#198/231
Net Assets	46.92B KRW	KR#1,950/2,421 Sec#163/231
Value
P/E	15.30x	KR#1,049/2,421 Sec#62/231
P/B	0.97x	KR#1,433/2,421 Sec#90/231
P/S	2.31x	KR#1,884/2,421 Sec#109/231
FCF Yield	3.76%	KR#937/2,421 Sec#56/231
Profitability
ROE	6.32%	KR#951/2,421 Sec#67/231
ROA	5.87%	KR#638/2,421 Sec#52/231
Op. Margin	10.98%	KR#473/2,421 Sec#42/231
Revenue Growth	2.56%	KR#1,346/2,421 Sec#134/231
Earnings Growth	-22.29%	KR#940/2,421 Sec#60/231
Financial Health
Debt Ratio	7.72%	KR#83/2,421 Sec#17/231
FCF	1.71B KRW	KR#1,104/2,421 Sec#80/231
Cash	3.35B KRW	KR#2,138/2,421 Sec#200/231
Current Ratio	5.98x	KR#218/2,421 Sec#44/231
Dividend
Div. Yield	4.62%	KR#327/2,421 Sec#11/231
Div. Growth	12.12%	KR#559/2,421 Sec#31/231
Performance
1Y Return	-35.03%	KR#1,709/2,421 Sec#138/231
1M Return	-3.25%	KR#1,613/2,421 Sec#128/231
From 52W High	-47.79%	KR#1,281/2,421 Sec#97/231
1Y MDD	-46.78%	KR#843/2,421 Sec#69/231
Trading
Volume	1,676 shares	KR#2,289/2,421 Sec#217/231
Trading Value	6.7M KRW	KR#2,317/2,421 Sec#219/231
Foreign Own.	0.67%	KR#2,154/2,421 Sec#209/231
Per Share
EPS	262 KRW	KR#1,210/2,421 Sec#82/231
BPS	4,151 KRW	KR#1,632/2,421 Sec#118/231